Versigent PLC Reports Third Quarter 2026 Financial Results
Versigent PLC reported third-quarter 2026 net sales of $2.45 billion, up 7.2% year over year, and Adjusted EBITDA of $275 million, up 10.9%, with an 11.2% margin. Net income fell to $102 million from $109 million a year earlier, which the company attributed to higher interest expenses. Versigent projected full-year 2026 net sales of $9.5 billion–$9.6 billion, Adjusted EBITDA of $970 million–$1.01 billion, and free cash flow of $275 million–$325 million. Its board declared a quarterly dividend of $0.13 per share.